Literature DB >> 8819652

Primary IgA nephropathy: a preliminary report.

S Sehgal1, B N Datta, V Sakhuja, K S Chugh.   

Abstract

A total of 106 renal biopsies were examined. Each biopsy was processed for routine paraffin sectioning and frozen sectioning. Direct immunofluorescence was done by the conventional method. The immunofluorescence patterns were correlated with histopathological changes and clinical presentation. Fourteen biopsies revealed weak to strong IgA staining and out of these, 11 seemed to fulfil the criteria of primary IgA nephropathy. These cases were diagnosed in a brief period of eleven months and there had not been any earlier published series from India.

Entities:  

Mesh:

Year:  1995        PMID: 8819652

Source DB:  PubMed          Journal:  Indian J Pathol Microbiol        ISSN: 0377-4929            Impact factor:   0.740


  3 in total

1.  Role of myofibroblasts and collagen type IV in patients of IgA nephropathy as markers of renal dysfunction.

Authors:  R W Minz; A Bakshi; S Chhabra; K Joshi; V Sakhuja
Journal:  Indian J Nephrol       Date:  2010-01

2.  Correlation of Oxford MEST-C Scores With Clinical Variables for IgA Nephropathy in South India.

Authors:  Swarnalata Gowrishankar; Yashita Gupta; Mahesha Vankalakunti; Kiran K Gowda; Anila A Kurien; K S Jansi Prema; N V Seethalekshmy; Jyotsna Yesodharan
Journal:  Kidney Int Rep       Date:  2019-07-03

3.  Protocol and rationale for the first South Asian 5-year prospective longitudinal observational cohort study and biomarker evaluation investigating the clinical course and risk profile of IgA nephropathy: GRACE IgANI cohort.

Authors:  Suceena Alexander; George T John; Anila Korula; T S Vijayakumar; Vinoi George David; Anjali Mohapatra; Anna T Valson; Shibu Jacob; Pradeep Mathew Koshy; Gautam Rajan; Elenjickal Elias John; Smita Mary Matthai; L Jeyaseelan; Babu Ponnusamy; Terence Cook; Charles Pusey; Mohamed R Daha; John Feehally; Jonathan Barratt; Santosh Varughese
Journal:  Wellcome Open Res       Date:  2018-07-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.